Femasys received its European Union Medical Device Regulation certificate and CE Mark certification for four of its products. The four products – FemaSeed, FemVue, FemCerv, and FemCath – are compliant with the new European Union legislation for medical devices. The MDR certification and the four CE Mark product approvals allow Femasys to deliver its innovative solutions for women’s reproductive health within the EU market.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative
- Femasys CEO Kathy-Lee Sepsick meets with White House’s OSTP
- Femasys CEO Kathy-Lee Sepsick meets with White House’s Gender Policy Council
- Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
- Femasys price target raised to $13 from $12 at H.C. Wainwright